HOME › DRUGS › AMPRENAVIR
ACTIVE SUBSTANCE / INN

AMPRENAVIR

Brand name(s): AGENERASE, Agenerase
FDA LISTED
EMA LISTED
WITHDRAWN
DISCONTINUED
NDA021039
HIV Infections
ACTIVE SUBSTANCE
Amprenavir
REGULATORS
FDA · EMA
SPONSORS / MAH
GLAXOSMITHKLINE, Glaxo Group Ltd.
TOTAL APPLICATIONS
2
FDA APPLICATIONS (DRUGS@FDA)
BRAND NAMEAPPLICATIONSPONSORSTATUS
AGENERASENDA021039GLAXOSMITHKLINEDiscontinued
EMA AUTHORISATIONS
PRODUCT NAMEHOLDERSTATUSDATEINDICATION
AgeneraseGlaxo Group Ltd.Withdrawn20/10/2000HIV Infections

FULL INTELLIGENCE ON AMPRENAVIR

Patent cliffs, clinical trials, pipeline data, AI-enriched regulatory signals — free on PharmaSignal.

OPEN PLATFORM →